PL398658A1 - Doustna szczepionka zawierajaca przetrwalniki Bacillus subtilis oraz jej zastosowanie do immunizacji przeciwko Helicobacter pylori - Google Patents

Doustna szczepionka zawierajaca przetrwalniki Bacillus subtilis oraz jej zastosowanie do immunizacji przeciwko Helicobacter pylori

Info

Publication number
PL398658A1
PL398658A1 PL398658A PL39865812A PL398658A1 PL 398658 A1 PL398658 A1 PL 398658A1 PL 398658 A PL398658 A PL 398658A PL 39865812 A PL39865812 A PL 39865812A PL 398658 A1 PL398658 A1 PL 398658A1
Authority
PL
Poland
Prior art keywords
spores
helicobacter pylori
oral vaccine
bacillus subtilis
immunization against
Prior art date
Application number
PL398658A
Other languages
English (en)
Other versions
PL218700B1 (pl
Inventor
Krzysztof Hine
Michał Obuchowski
Ezio Ricca
Original Assignee
Gdanski Uniwersytet Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gdanski Uniwersytet Medyczny filed Critical Gdanski Uniwersytet Medyczny
Priority to PL398658A priority Critical patent/PL218700B1/pl
Priority to PCT/PL2013/000040 priority patent/WO2013147628A2/en
Priority to EP13723573.5A priority patent/EP2852394B1/en
Publication of PL398658A1 publication Critical patent/PL398658A1/pl
Publication of PL218700B1 publication Critical patent/PL218700B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem wynalazku jest doustna szczepionka zawierajaca przetrwalniki Bacillus subtilis jako nosnik antygenu, bialka ureazy UreA, UreB Helicobacter pylori lub Helicobacter acinonychis jako antygen oraz bialka plaszcza antygenu CotB, CotC, CotG, CotZ oraz zastosowanie przetrwalników Bacillus subtilis do wytwarzania doustnej szczepionki stosowanej do immunizacji ssaka przeciwko Helicobacter pylori u pacjentów z choroba wrzodowa zoladka i dwunastnicy.
PL398658A 2012-03-29 2012-03-29 Doustna szczepionka zawierająca przetrwalniki Bacillus subtilis oraz jej zastosowanie do immunizacji przeciwko Helicobacter pylori PL218700B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL398658A PL218700B1 (pl) 2012-03-29 2012-03-29 Doustna szczepionka zawierająca przetrwalniki Bacillus subtilis oraz jej zastosowanie do immunizacji przeciwko Helicobacter pylori
PCT/PL2013/000040 WO2013147628A2 (en) 2012-03-29 2013-03-27 Oral vaccine containing the bacillus subtilis spores and its application to immunise against helicobacter pylori
EP13723573.5A EP2852394B1 (en) 2012-03-29 2013-03-27 Oral vaccine containing the bacillus subtilis spores and its application to immunise against helicobacter pylori

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL398658A PL218700B1 (pl) 2012-03-29 2012-03-29 Doustna szczepionka zawierająca przetrwalniki Bacillus subtilis oraz jej zastosowanie do immunizacji przeciwko Helicobacter pylori

Publications (2)

Publication Number Publication Date
PL398658A1 true PL398658A1 (pl) 2013-09-30
PL218700B1 PL218700B1 (pl) 2015-01-30

Family

ID=48464058

Family Applications (1)

Application Number Title Priority Date Filing Date
PL398658A PL218700B1 (pl) 2012-03-29 2012-03-29 Doustna szczepionka zawierająca przetrwalniki Bacillus subtilis oraz jej zastosowanie do immunizacji przeciwko Helicobacter pylori

Country Status (3)

Country Link
EP (1) EP2852394B1 (pl)
PL (1) PL218700B1 (pl)
WO (1) WO2013147628A2 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
US5972336A (en) 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
CN100460013C (zh) 2006-09-05 2009-02-11 重庆康卫生物科技有限公司 口服重组幽门螺杆菌疫苗及其制备方法

Also Published As

Publication number Publication date
PL218700B1 (pl) 2015-01-30
EP2852394B1 (en) 2019-02-20
WO2013147628A2 (en) 2013-10-03
WO2013147628A3 (en) 2013-12-12
EP2852394A2 (en) 2015-04-01

Similar Documents

Publication Publication Date Title
MX2025007897A (es) Dosis y administracion de anticuerpos anti-c5 para el tratamiento de la hemoglobinuria paroxistica nocturna (hpn) y el sindrome hemolitico uremico atipico (shua)
WO2017123636A8 (en) Dosage and administration of anti-c5 antibodies for treatment
PH12017501417A1 (en) Anti-fap antibodies and methods of use
HN2012001223A (es) Antagonistas de pcsk 9
EA201490303A1 (ru) Вакцина
WO2012021786A3 (en) Anti-hemagglutinin antibody compositions and methods of use thereof
MX421186B (es) Constructos de anticuerpos.
TR201802380T4 (tr) Benzonaftiridin içeren aşılar.
MX2012013268A (es) Formulaciones de anticuerpos de alta concentracion.
EA201171060A1 (ru) Молекулы антител, обладающих специфичностью к человеческому ох40
MY169352A (en) Vaccine against rsv
MX390278B (es) Formulaciones de vacuna de vial unico.
EA201790239A1 (ru) Молекула-носитель для антигенов
UA110103C2 (uk) Модифікований туберкульозний антиген
MY163871A (en) Vaccines and compositions against streptococcus pneumoniae
MX349948B (es) Proteínas inmunógenas y composiciones para el tratamiento y prevención de streptococcus agalactiae.
PH12013500222A1 (en) Compositions and methods for treating hepatitis virus infection
EP3630172A4 (en) COMPOSITIONS AND METHODS FOR TUMOR VACCINATION AND IMMUNOTHERAPY WITH THEIR ANTIGENS
MX357146B (es) Formulaciones estabilizadas que contienen anticuerpos anti-dll4.
EP3897181A4 (en) ORAL EGG IMMUNOTHERAPY FORMULATIONS, METHODS OF MAKING AND TREATMENTS FOR EGG ALLERGY
PL404229A1 (pl) Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie
MX349657B (es) Composiciones de vacuna de matriz de proteína que incluyen policationes.
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
PH12014501795A1 (en) Rota virus subunit vaccines and methods of making and use thereof
CY1123219T1 (el) Βελτιωμενα αντισωματα αλφα v βητα 8